Key result
The Eberson Colloidal Gold Test did not distinguish between serums from poliomyelitis convalescent monkeys and normal monkeys, indicating it is not specific for poliomyelitis antibodies.
Why the study?
Is the Eberson Colloidal Gold Test specific for the detection of poliomyelitis antibodies in monkey serum?
Is the Eberson Colloidal Gold Test specific for the detection of poliomyelitis antibodies in monkey serum?
The Eberson Colloidal Gold Test is not specific for poliomyelitis antibodies, as its reactions appear to be driven by non-specific serum ingredients rather than specific antibodies.
Answers are grounded in this paper and cite their sources.
Eberson test lacks specificity in monkeys; leaves open its diagnostic utility in humans and requires clinical validation.
Summary and Conclusions Colloidal gold tests carried out according to the procedure described by Eberson did not enable us to distinguish between serums collected from poliomyelitis convalescent monkeys and normal monkeys (M. rhesus). The test therefore does not seem to be in any sense specific for the detection of poliomyelitis antibodies. The reactions described are apparently due to an adsorption of gold particles by some unidentified ingredients of the serum with a subsequent “settling out” of these aggregates after becoming “coated” with gold. The substance in the serum which is responsible for this phenomenon seems to fluctuate in amount and may be closely related to food stuffs absorbed by the blood from the alimentary tract.
No takes yet. Share an insight, caveat, or question.
Schultz et al. (1934) studied Poliomyelitis. Eberson Colloidal Gold Test vs. Normal monkeys was evaluated on Ability to distinguish between serums from convalescent and normal monkeys. The Eberson Colloidal Gold Test did not distinguish between serums from poliomyelitis convalescent monkeys and normal monkeys, indicating it is not specific for poliomyelitis antibodies.
Synapse has enriched 10 related papers. Consider them for comparative context: